CAV1 and pulmonary fibrosis: Current research demonstrates the therapeutic potential of the Cav-1/autophagy axis (possible therapeutic targets are shown in Table 1). For example, CSP7 ameliorates pulmonary fibrosis; hydroxychloroquine inhibits breast cancer; AAV9-mediated Cav-1 delivery rescues neuronal function in diabetes.